chr1-228211818-T-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001386125.1(OBSCN):​c.35T>A​(p.Phe12Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00467 in 1,561,674 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F12V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0032 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0048 ( 26 hom. )

Consequence

OBSCN
NM_001386125.1 missense

Scores

7
3
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 6.15

Publications

7 publications found
Variant links:
Genes affected
OBSCN (HGNC:15719): (obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF) The obscurin gene spans more than 150 kb, contains over 80 exons and encodes a protein of approximately 720 kDa. The encoded protein contains 68 Ig domains, 2 fibronectin domains, 1 calcium/calmodulin-binding domain, 1 RhoGEF domain with an associated PH domain, and 2 serine-threonine kinase domains. This protein belongs to the family of giant sacromeric signaling proteins that includes titin and nebulin, and may have a role in the organization of myofibrils during assembly and may mediate interactions between the sarcoplasmic reticulum and myofibrils. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
OBSCN-AS1 (HGNC:32047): (OBSCN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015575349).
BP6
Variant 1-228211818-T-A is Benign according to our data. Variant chr1-228211818-T-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 523062.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0032 (486/151870) while in subpopulation NFE AF = 0.00533 (362/67890). AF 95% confidence interval is 0.00488. There are 1 homozygotes in GnomAd4. There are 207 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 26 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OBSCNNM_001386125.1 linkc.35T>A p.Phe12Tyr missense_variant Exon 2 of 116 ENST00000680850.1 NP_001373054.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OBSCNENST00000680850.1 linkc.35T>A p.Phe12Tyr missense_variant Exon 2 of 116 NM_001386125.1 ENSP00000505517.1 A0A7P0Z489

Frequencies

GnomAD3 genomes
AF:
0.00321
AC:
487
AN:
151752
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00288
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000833
Gnomad FIN
AF:
0.000756
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00533
Gnomad OTH
AF:
0.00527
GnomAD2 exomes
AF:
0.00339
AC:
692
AN:
204082
AF XY:
0.00357
show subpopulations
Gnomad AFR exome
AF:
0.000930
Gnomad AMR exome
AF:
0.00223
Gnomad ASJ exome
AF:
0.00213
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000986
Gnomad NFE exome
AF:
0.00581
Gnomad OTH exome
AF:
0.00390
GnomAD4 exome
AF:
0.00483
AC:
6810
AN:
1409804
Hom.:
26
Cov.:
72
AF XY:
0.00469
AC XY:
3260
AN XY:
695058
show subpopulations
African (AFR)
AF:
0.000933
AC:
30
AN:
32166
American (AMR)
AF:
0.00251
AC:
98
AN:
39072
Ashkenazi Jewish (ASJ)
AF:
0.00160
AC:
37
AN:
23120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38908
South Asian (SAS)
AF:
0.000971
AC:
77
AN:
79260
European-Finnish (FIN)
AF:
0.00164
AC:
82
AN:
49998
Middle Eastern (MID)
AF:
0.00306
AC:
15
AN:
4906
European-Non Finnish (NFE)
AF:
0.00570
AC:
6180
AN:
1084530
Other (OTH)
AF:
0.00503
AC:
291
AN:
57844
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
400
800
1201
1601
2001
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00320
AC:
486
AN:
151870
Hom.:
1
Cov.:
33
AF XY:
0.00279
AC XY:
207
AN XY:
74230
show subpopulations
African (AFR)
AF:
0.00121
AC:
50
AN:
41452
American (AMR)
AF:
0.00288
AC:
44
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5086
South Asian (SAS)
AF:
0.000834
AC:
4
AN:
4796
European-Finnish (FIN)
AF:
0.000756
AC:
8
AN:
10586
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00533
AC:
362
AN:
67890
Other (OTH)
AF:
0.00521
AC:
11
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
28
55
83
110
138
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00356
Hom.:
1
Bravo
AF:
0.00355
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00467
AC:
18
ESP6500AA
AF:
0.000751
AC:
3
ESP6500EA
AF:
0.00571
AC:
47
ExAC
AF:
0.00355
AC:
426
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 18, 2017
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

OBSCN: PP3, BS2 -

OBSCN-related disorder Benign:1
May 30, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.17
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Benign
0.076
.;T;.;.;T
Eigen
Pathogenic
0.69
Eigen_PC
Uncertain
0.55
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.89
D;D;D;.;.
M_CAP
Benign
0.071
D
MetaRNN
Benign
0.016
T;T;T;T;T
MetaSVM
Uncertain
0.30
D
MutationAssessor
Pathogenic
3.1
M;M;.;.;M
PhyloP100
6.2
PrimateAI
Pathogenic
0.86
D
PROVEAN
Benign
-1.8
N;N;N;.;.
REVEL
Pathogenic
0.67
Sift
Benign
0.093
T;T;T;.;.
Sift4G
Pathogenic
0.0
D;D;D;D;.
Polyphen
1.0
D;D;.;.;D
Vest4
0.50
MVP
0.70
MPC
2.3
ClinPred
0.051
T
GERP RS
4.8
PromoterAI
-0.0052
Neutral
Varity_R
0.74
gMVP
0.64
Mutation Taster
=259/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs191837710; hg19: chr1-228399519; API